Cara Therapeutics Inc. (CARA) Has Broken Out To A New High On Study Results
Markets2018-06-27
20 Views
Cara Therapeutics Inc. (CARA) announced Wednesday morning that its Phase 2/3 trial of I.V. CR845 in patients undergoing abdominal surgeries demonstrated statistically significant reductions in pain intensity compared to placebo.
Source: RTTNews
The news, reports, views and opinions of authors (or source) expressed are their own and do not necessarily represent the views of CRWE World.
How Animated Explainer Videos Communicate Ideas Visually
Lightning Safety Planning for Homeowners and Families
